
Disparities in Integrase Inhibitor Usage in the Modern HIV Treatment Era: A Population-Based Study in a US City
Author(s) -
Matthew A Spinelli,
Nancy A. Hessol,
Sandra Schwarcz,
Susan Scheer,
Monica Gandhi,
Ling Hsu
Publication year - 2021
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofab139
Subject(s) - integrase , medicine , integrase inhibitor , antiretroviral therapy , human immunodeficiency virus (hiv) , gerontology , family medicine , viral load
Integrase inhibitor–based (INSTI) antiretroviral therapy (ART) regimens are preferred for most people with HIV (PWH). We examined factors associated with INSTI use among PWH in San Francisco who started ART in 2009–2016. PWH who experienced homelessness were less likely, and older PWH were more likely, to use an INSTI.